Immunome IMNM
NASDAQ IMNM
$21.89 +0.21 (+0.97%)
At close: Sep 29, 2026 · 4:00 PM EDT

Immunome (IMNM) Net Margin (2023 - 2025)

Updated

Immunome (IMNM) recorded Net Margin of -3059.99% in FY2025, up 180.39 percentage points from -3240.38% in FY2024.

Analysis

Immunome (IMNM) Net Margin (2023 - 2025) Analysis & Trends

  • Per Business Quant data, IMNM's Net Margin was -3240.38% in FY2024 (-2478.46 pp) and -761.92% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 21.86%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 21.27%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -8.04%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 22.61%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.81%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 23.62%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 32.99%
10 Immunome 2.46 Bn 429.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1,080.87%
Mar 31, 2025 -1,423.10%
Dec 31, 2024 -2,930.93%
Sep 30, 2024 -1,618.56%
Jun 30, 2024 -1,528.00%
Mar 31, 2024 -12,584.26%
Dec 31, 2023 -2,421.17%
Sep 30, 2023 -121.88%
Jun 30, 2023 -130.35%
Mar 31, 2023 -180.63%
API Access

Immunome Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=IMNM&period=max&api_key=YOUR_API_KEY